Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Operating Expenses | 55,028 | 58,433 | 52,976 | 53,813 | 50,119 |
| Operating Income | -55,028 | -58,433 | -52,976 | -53,813 | -50,119 |
| Interest Expense | 1,144 | 0 | 0 | 0 | 0 |
| Other Income | 1,935 | 1,417 | 1,303 | 1,294 | 636 |
| Pre-tax Income | -54,237 | -57,016 | -51,673 | -52,519 | -49,483 |
| Income Tax | 29 | -18 | 29 | 33 | 17 |
| Net Income Continuous | -54,266 | -56,998 | -51,702 | -52,552 | -49,500 |
| Net Income | $-54,266 | $-56,998 | $-51,702 | $-52,552 | $-49,500 |
| EPS Basic Total Ops | -0.87 | -0.95 | -0.89 | -0.91 | -0.92 |
| EPS Basic Continuous Ops | -0.87 | -0.95 | -0.89 | -0.91 | -0.92 |
| EPS Diluted Total Ops | -0.87 | -0.95 | -0.89 | -0.91 | -0.92 |
| EPS Diluted Continuous Ops | -0.87 | -0.95 | -0.89 | -0.91 | -0.92 |
| EPS Diluted Before Non-Recurring Items | -0.87 | -0.95 | N/A | N/A | N/A |
| EBITDA(a) | $-54,904 | $-58,313 | $-52,897 | $-53,631 | $-49,788 |